Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia

Documenti analoghi

• PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia
  di: Govaerts, Inge, et al.
  Pubblicazione: (2021)
• Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia
  di: Albertí-Servera, Llucia, et al.
  Pubblicazione: (2021)
• Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing
  di: Sarah Meyers, et al.
  Pubblicazione: (2022-04-01)
• JAK1 mutation analysis in T-cell acute lymphoblastic leukemia cell lines
  di: Porcu, Michaël, et al.
  Pubblicazione: (2009)
• Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia
  di: De Bie, Jolien, et al.
  Pubblicazione: (2018)